NCT07614165

Brief Summary

People using HIV self-testing (HIVST) need access to quality HIV-prevention programming, including education and exploration of pre-exposure prophylaxis (PrEP) - an effective biomedical prevention tool that continues to expand in choices and access points in the US. HIVST and PrEP are both central to ending the HIV epidemic, but presently they are not linked together in a systematic way. To address the critical need for PrEP programming to accompany HIV self-testing (HIVST), our study will work with experts and HIVST users to develop and pilot a novel, interactive, mobile friendly PrEP decisional-aid mobile optimized website that helps to raise awareness around PrEP and guides people through a PrEP-decision-making process that matches their needs and values, and links people to resources for local or online PrEP. This PrEP Decisional Aid to accompany Self HIV-test kits (the DASH app) will be in a randomized controlled pilot trial with 120-170 HIV self-test kit users in the CDC's Together TakeMeHome HIV-test kit dissemination program. PrEP uptake at 3-months (primary outcome) will be compared between arms descriptively and with logistic regression models. Change in additional PrEP related factors (knowledge, stigma, decisional conflict, barriers and facilitators) will be assessed as secondary outcomes. Implementation metrics, acceptability and feasibility will also be evaluated quantitatively and qualitatively. Results will inform revisions and recommendations for a decisional aid for raising PrEP awareness and use among self HIV-test users.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
170

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Apr 2026Dec 2026

Study Start

First participant enrolled

April 17, 2026

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

May 8, 2026

Completed
21 days until next milestone

First Posted

Study publicly available on registry

May 29, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

June 3, 2026

Status Verified

May 1, 2026

Enrollment Period

7 months

First QC Date

May 8, 2026

Last Update Submit

May 29, 2026

Conditions

Keywords

Pre-exposure Prophylaxis (PrEP)HIV preventionHIV Self-testingDecisional Aid

Outcome Measures

Primary Outcomes (2)

  • PrEP Start

    Self-reported PrEP initiation determined by a single item asking "Are you currently using PrEP?" \[Yes/No\]

    3 months

  • Theoretical Framework of Acceptability Scale for DASH

    Adapted from the Theoretical Framework of Acceptability Scale. 9 items assess affective attitudes, burden, perceived effectiveness, intervention coherence, opportunity costs, self-efficacy and ethicality- with likert scale of 1 to 5. A total acceptability score can be calculated by summing responses to items producing a range of 9 to 45 with higher scores reflecting higher overall acceptability.

    Month 1 and month 3

Secondary Outcomes (2)

  • PrEP Information

    Baseline, Month 1 and Month 3

  • Movement on PrEP Care Continuum

    Baseline, Month 1 and Month 3

Other Outcomes (6)

  • Decisional Conflict

    Baseline, Month 1 and Month 3

  • PrEP Motivation

    Baseline, Month 1 and Month 3

  • DASH Trustworthiness

    Month 1

  • +3 more other outcomes

Study Arms (2)

Comparison condition

NO INTERVENTION

Participants in the comparison condition do not receive additional PrEP related information through the project- but have access to PrEP information from the self-test kit and other programs that are available.

DASH Intervention Arm

EXPERIMENTAL

Participants receive access to the DASH app through an emailed link with reminders to use the link at least one during the 3 month study period

Behavioral: PrEP Decisional Aid for dissemination with Self-administered HIV test kits (DASH)

Interventions

Participants assigned to the intervention arm will be provided with a unique code to access the login for the DASH app. The app provides a PrEP information, explores values and decisions around PrEP, and leads participants through an exploration of their PrEP decisions with links to PrEP resources (local and online) for those interested in findings out more about or starting PrEP. Participants are asked to complete one complete session and return back to the app at any time during their participation.

DASH Intervention Arm

Eligibility Criteria

Age18 Years - 39 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-39
  • Comfort with English material and communication (oral and written)
  • Access to internet
  • HIV negative (self-report)
  • PrEP Naive (never used PrEP)

You may not qualify if:

  • Ever used PrEP

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

Study Officials

  • K Rivet Amico, PhD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized controlled mixed methods implementation hybrid type 1 pilot study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Health Behavior and Health Equity and Professor of Global Public Health, School of Public Health

Study Record Dates

First Submitted

May 8, 2026

First Posted

May 29, 2026

Study Start

April 17, 2026

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

June 3, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

National Data Archive received participant data using a psuedo identification number

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
NDA data is uploaded quarterly and is available to public for use after the completion of the trial
Access Criteria
NDA has a system that researchers can use to request data access
More information

Locations